By Development Alert | Project Leader
Dear Donor,
Thank you for standing with Development Alert as communities and health systems continue to face the challenges of the Bundibugyo virus outbreak.
The DRC has reported more than 5,000 Ebola-related deaths, while Kenya has recorded nine confirmed cases and two deaths. Nigeria is also investigating two additional suspected cases following its first confirmed imported case. These developments underline the urgent need for sustained prevention and stronger healthcare preparedness.
There is also an important scientific development. On 23 October, the TUMAINI Phase 2/3 clinical trial of vaccine candidates against Bundibugyo virus disease was launched in Bunia, in the DRC's Ituri Province. This research aims to generate evidence that could contribute to future protection against this strain.
However, research is not the same as an approved vaccine. There is currently no approved vaccine specifically for Bundibugyo virus disease, making early detection, appropriate supportive medical care, infection prevention, and community engagement essential.
Frontline health workers also need adequate protective equipment, reliable supplies, safe working procedures, and continued training. Communities need trustworthy information so they can seek care early and avoid unsafe practices.
Development Alert remains committed to promoting community awareness and preparedness while supporting the wider goal of protecting vulnerable people.
Your support helps keep prevention, dignity, and community resilience at the heart of our work. Thank you for standing with us.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser